Almulla
 
Group profile Areas of Operation News Careers Contact us Home
Healthcare

Print this page Font Big Font Medium Font Smaill
Healthcare


MONROL UAE - a new joint venture

A new joint venture between Almulla Group’s UNIMED and Monrol UAE is constructing a manufacturing plant in Dubai that will advance cancer treatment in the UAE by supplying radiopharmaceuticals locally and that can assist in the early detection of tumors.

MONROLUnited Medical Supplies (Unimed) L.L.C, a registered and licensed Medical and Pharmaceutical company in UAE, owned and operated by Mohamed & Obaid Almulla L.L.C., has signed a Consultation and Management agreement with Monrol to undertake the supervision, startup, test production, routine production and delivery of radiopharmaceuticals to Hospitals in the UAE and the surrounding countries, operating as Monrol UAE.

The aim is to become the leader in this field with Monrol UAE operating a radiopharmaceutical production plant in Dubai producing sterile, pyrogen-free fluoro-deoxy glucose solution for injection used as an imaging agent in Positron Emission Tomography (PET) which is a nuclear medicine diagnosis method.

The production, research and quality control laboratories, offices and other support units will be based in a two-storey building to be constructed over an area of 1,000 square metres.

MONROL UAE - a new joint venture
Positron Emission Tomography (PET), which is a relatively new imaging technology, allows the diagnosis or staging of many diseases, especially cancer even in early stage. The solution is a product ready to inject directly into patients intravenously, once it is prepared.
The new facility will focus on two main tasks; the production of the solution, and research and development activities.

The half-life of radioisotopes is very short and their efficacy can sometimes be measured in hours, which means that radiopharmaceutics - especially PET radiopharmaceutics, which have a half-life of 109.8 minutes – must be applied to patients in diagnosis centres close to the plant where they are produced, such as the American Hospital Dubai and other private and public hospitals in the UAE.

The solution will be manufactured in accordance with the regulations of the UAE Ministry of Health, and the procedures relating to the radiation safety and protection of the staff and plant conditions shall be undertaken in accordance with the regulations of the United Arab Emirates Radiation Protection Control Department (RPCD). The audits and controls on the products and plant shall be conducted by the relevant ministries and authorities.

www.monrol-uae.com

206, 2nd Floor | Almulla Building | Baniyas Street | P.O. Box 59 | Deira, Dubai | United Arab Emirates
Phone+971 (04) 2221241   Fax+971 (04) 2218109   Mailsec.moa@almulla.com

News
News
Competing against the industry’s leading operators, Abjar Hotels International LLC was presented with the following awards.
Read More >>
Our areas of operations
Our areas of operations
Healthcare
Hospitality
Travel & Tourism
Real Estate
Jewellery & Watches